The mouse models of Tsc2 inactivation presented here do not replicate the typical genetic mechanisms of kidney disease in human TSC, in which a germline “first hit” mutation is followed by a stochastic “second hit” mutation, but they clearly indicate that in the mouse kidney, TFEB plays a critical role in TSC-associated pathology. This evidence concerns the gene TSC2 and kidney disorder.